Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1971 1
1972 1
1973 1
1974 1
1975 1
1976 2
1978 1
1979 3
1980 4
1981 2
1982 2
1983 5
1984 1
1985 2
1987 1
1989 2
1990 1
1991 3
1992 3
1993 2
1994 2
1995 1
1996 4
1997 7
1998 4
1999 7
2000 6
2001 4
2002 5
2003 3
2004 7
2005 6
2006 8
2007 6
2008 5
2009 5
2010 8
2011 7
2012 9
2013 12
2014 10
2015 5
2016 9
2017 25
2018 12
2019 16
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

223 results
Results by year
Filters applied: . Clear all
Page 1
Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.
Langer-Gould A, Wu J, Lucas R, Smith J, Gonzales E, Amezcua L, Haraszti S, Chen LH, Quach H, James JA, Barcellos LF, Xiang AH. Langer-Gould A, et al. Neurology. 2017 Sep 26;89(13):1330-1337. doi: 10.1212/WNL.0000000000004412. Epub 2017 Aug 30. Neurology. 2017. PMID: 28855411 Free PMC article.
OBJECTIVE: To determine whether Epstein-Barr virus (EBV) or cytomegalovirus (CMV) seropositivity is associated with multiple sclerosis (MS) in blacks and Hispanics and to what extent measures of the hygiene hypothesis or breastfeeding could explain these find …
OBJECTIVE: To determine whether Epstein-Barr virus (EBV) or cytomegalovirus (CMV) seropositivity is associated with multiple
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.
Olsson T, Barcellos LF, Alfredsson L. Olsson T, et al. Nat Rev Neurol. 2017 Jan;13(1):25-36. doi: 10.1038/nrneurol.2016.187. Epub 2016 Dec 9. Nat Rev Neurol. 2017. PMID: 27934854 Review.
Genetic predisposition to multiple sclerosis (MS) only explains a fraction of the disease risk; lifestyle and environmental factors are key contributors to the risk of MS. ...Organic solvents and shift work have also been reported to confer increased risk of the dis …
Genetic predisposition to multiple sclerosis (MS) only explains a fraction of the disease risk; lifestyle and environmental fa …
Cytomegalovirus primary infection in a patient with multiple sclerosis treated with alemtuzumab.
Aguirre C, Meca-Lallana V, Sánchez P, Vivancos J. Aguirre C, et al. Mult Scler Relat Disord. 2019 Oct;35:270-271. doi: 10.1016/j.msard.2019.07.026. Epub 2019 Aug 6. Mult Scler Relat Disord. 2019. PMID: 31442904
Alemtuzumab is an anti-CD52 monoclonal antibody approved for the treatment of multiple sclerosis (MS). It produces rapid depletion of T and B lymphocytes, which could predispose to opportunistic infections. We report one patient with MS who develops cytomegalovir
Alemtuzumab is an anti-CD52 monoclonal antibody approved for the treatment of multiple sclerosis (MS). It produces rapid deple …
HLA alleles modulate EBV viral load in multiple sclerosis.
Agostini S, Mancuso R, Guerini FR, D'Alfonso S, Agliardi C, Hernis A, Zanzottera M, Barizzone N, Leone MA, Caputo D, Rovaris M, Clerici M. Agostini S, et al. J Transl Med. 2018 Mar 27;16(1):80. doi: 10.1186/s12967-018-1450-6. J Transl Med. 2018. PMID: 29587799 Free PMC article.
BACKGROUND: The etiopathology of multiple sclerosis (MS) is believed to include genetic and environmental factors. Human leukocyte antigen (HLA) alleles, in particular,  are associated with disease susceptibility, whereas Epstein Barr Virus (EBV) infection has long …
BACKGROUND: The etiopathology of multiple sclerosis (MS) is believed to include genetic and environmental factors. Human leuko …
Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?
Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeño JC, Villar LM, López-Botet M, Martínez-Rodríguez JE. Alari-Pahissa E, et al. Eur J Neurol. 2018 Jul;25(7):925-933. doi: 10.1111/ene.13622. Epub 2018 Apr 15. Eur J Neurol. 2018. PMID: 29528545
BACKGROUND AND PURPOSE: Cytomegalovirus (CMV) infection has recently been associated with a lower multiple sclerosis (MS) susceptibility, although it remains controversial whether it has a protective role or is merely an epiphenomenon related to westernizatio …
BACKGROUND AND PURPOSE: Cytomegalovirus (CMV) infection has recently been associated with a lower multiple sclerosis (M …
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F. Serafini B, et al. J Virol. 2019 Nov 26;93(24):e00980-19. doi: 10.1128/JVI.00980-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578295 Free PMC article.
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus strongly associated with multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS). ...Brain sections were stained with HLA-matched pentamers coupled with immunogenic peptides fro …
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus strongly associated with multiple sclerosis (MS), a chronic inflammatory …
Cytomegalovirus: a culprit or protector in multiple sclerosis?
Vanheusden M, Stinissen P, 't Hart BA, Hellings N. Vanheusden M, et al. Trends Mol Med. 2015 Jan;21(1):16-23. doi: 10.1016/j.molmed.2014.11.002. Epub 2014 Nov 20. Trends Mol Med. 2015. PMID: 25500015
Multiple sclerosis (MS) is a chronic disabling autoimmune disease of the central nervous system (CNS). Cytomegalovirus (CMV), a β herpes virus, may have a detrimental or beneficial role in MS pathology. ...
Multiple sclerosis (MS) is a chronic disabling autoimmune disease of the central nervous system (CNS). Cytomegalovirus
Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis.
Lima MR, Farias LABG, da Ponte MF, de Arruda Furtado LET. Lima MR, et al. Eur J Case Rep Intern Med. 2019 Feb 1;6(2):001046. doi: 10.12890/2019_001046. eCollection 2019. Eur J Case Rep Intern Med. 2019. PMID: 30931272 Free PMC article.
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and delays the progression of physical disability. Here, we report the case of a 30-year-old patient with multiple sclerosis rece …
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and …
Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.
Munger KL, Hongell K, Cortese M, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A. Munger KL, et al. Ann Neurol. 2019 Sep;86(3):436-442. doi: 10.1002/ana.25532. Epub 2019 Jul 3. Ann Neurol. 2019. PMID: 31226219 Free PMC article.
OBJECTIVE: To determine whether maternal Epstein-Barr virus (EBV) IgG antibody levels are associated with risk of multiple sclerosis (MS) in the offspring. ...RESULTS: Maternal viral capsid antigen IgG levels during pregnancy were associated with an increased MS ris …
OBJECTIVE: To determine whether maternal Epstein-Barr virus (EBV) IgG antibody levels are associated with risk of multiple scleros
Herpesviridae Seropositivity in Patients with Multiple Sclerosis: First Polish Study.
Czarnowska A, Kapica-Topczewska K, Zajkowska O, Świerzbińska R, Chorąży M, Tarasiuk J, Zajkowska J, Kochanowicz J, Kułakowska A. Czarnowska A, et al. Eur Neurol. 2018;80(5-6):229-235. doi: 10.1159/000496402. Epub 2019 Jan 18. Eur Neurol. 2018. PMID: 30661064
BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that leads to inflammation, demyelination and neurodegeneration. ...OBJECTIVES: The present investigation aims to detect the presence of antibodies against the herpes s …
BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that leads to inflammation, …
223 results
Jump to page
Feedback